{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:13:44Z","timestamp":1785827624216,"version":"3.56.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/06350-4"],"award-info":[{"award-number":["2017\/06350-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00436-022-07628-y","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T04:02:41Z","timestamp":1661227361000},"page":"2849-2860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9665-3668","authenticated-orcid":false,"given":"Fabiana Rodrigues","family":"de Santana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-1260","authenticated-orcid":false,"given":"Danielle Aparecida Marino","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0457-6747","authenticated-orcid":false,"given":"Simone","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7074-605X","authenticated-orcid":false,"given":"Cristina Mary","family":"Orikaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8535-0901","authenticated-orcid":false,"given":"Katia Cristina","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9426-2308","authenticated-orcid":false,"given":"Clara L\u00facia","family":"Barbi\u00e9ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"issue":"2\u20134","key":"7628_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.vetpar.2011.05.009","volume":"181","author":"HM Andrade","year":"2011","unstructured":"Andrade HM, Toledo VP, Pinheiro MB, Guimar\u00e3es TM, Oliveira NC, Castro JA, Silva RN, Amorim AC, Brand\u00e3o RM, Yoko M, Silva AS, Dumont K, Ribeiro ML Jr, Bartchewsky W, Monte SJ (2011) Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil. Vet Parasitol 181(2\u20134):83\u201390. https:\/\/doi.org\/10.1016\/j.vetpar.2011.05.009","journal-title":"Vet Parasitol"},{"key":"7628_CR2","doi-asserted-by":"publisher","first-page":"105052","DOI":"10.1016\/j.actatropica.2019.105052","volume":"197","author":"RMF Arruda","year":"2019","unstructured":"Arruda RMF, Cardoso DT, Teixeira-Neto RG, Barbosa DS, Ferraz RK, Morais MHF, Belo VS, da Silva ES (2019) Space-time analysis of the incidence of human visceral leishmaniasis (VL) and prevalence of canine VL in a municipality of southeastern Brazil: Identification of priority areas for surveillance and control. Acta Trop 197:105052. https:\/\/doi.org\/10.1016\/j.actatropica.2019.105052","journal-title":"Acta Trop"},{"key":"7628_CR3","doi-asserted-by":"publisher","first-page":"e20190240","DOI":"10.1590\/0037-8682-0240-2019","volume":"52","author":"TS Azevedo","year":"2019","unstructured":"Azevedo TS, Lorenz C, Chiaravalloti-Neto F (2019) Risk mapping of visceral leishmaniasis in Brazil. Rev Soc Bras Med Trop 52:e20190240. https:\/\/doi.org\/10.1590\/0037-8682-0240-2019","journal-title":"Rev Soc Bras Med Trop"},{"issue":"4","key":"7628_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s0304-4017(02)00115-2","volume":"106","author":"G Baneth","year":"2002","unstructured":"Baneth G, Shaw SE (2002) Chemotherapy of canine leishmaniosis. Vet Parasitol 106(4):315\u2013324. https:\/\/doi.org\/10.1016\/s0304-4017(02)00115-2","journal-title":"Vet Parasitol"},{"issue":"2","key":"7628_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/0014-4894(90)90024-7","volume":"71","author":"CL Barbi\u00e9ri","year":"1990","unstructured":"Barbi\u00e9ri CL, Doine AI, Freymuller E (1990) Lysosomal depletion in macrophages from spleen and foot lesions of Leishmania-infected hamster. Exp Parasitol 71(2):218\u2013228. https:\/\/doi.org\/10.1016\/0014-4894(90)90024-7","journal-title":"Exp Parasitol"},{"issue":"1","key":"7628_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/AAC.31.1.111","volume":"31","author":"JD Berman","year":"1987","unstructured":"Berman JD, Hanson WL, Lovelace JK, Waits VB, Jackson JE, Chapman WL Jr, Klein RS (1987) Activity of purine analogs against Leishmania donovani in vivo. Antimicrob Agents Chemother 31(1):111\u2013113. https:\/\/doi.org\/10.1128\/AAC.31.1.111","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"7628_CR7","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1177\/0192623309344088","volume":"37","author":"P Bianciardi","year":"2009","unstructured":"Bianciardi P, Brovida C, Valente M, Aresu L, Cavicchioli L, Vischer C, Giroud L, Castagnaro M (2009) Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys. Toxicol Pathol 37(6):770\u2013775. https:\/\/doi.org\/10.1177\/0192623309344088","journal-title":"Toxicol Pathol"},{"issue":"1","key":"7628_CR8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2460\/ajvr.1993.54.01.113","volume":"54","author":"AA Binhazim","year":"1993","unstructured":"Binhazim AA, Chapman WL Jr, Shin SS, Hanson WL (1993) Determination of virulence and pathogenesis of a canine strain of Leishmania (Leishmania) infantum in hamsters and dogs. Am J Vet Res 54(1):113\u2013121","journal-title":"Am J Vet Res"},{"key":"7628_CR9","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","volume":"22","author":"GP Borja-Cabrera","year":"2004","unstructured":"Borja-Cabrera GP, Cruz Mendes A, Paraguai de Souza E, Hashimoto Okada LY, de A Trivellato FA, Kawasaki JK, Costa AC, Reis AB, Genaro O, Batista LM, Palatnik M, Palatnik-de-Sousa CB (2004) Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine. Vaccine 22:2234\u20132243. https:\/\/doi.org\/10.1016\/j.vaccine.2003.11.039","journal-title":"Vaccine"},{"issue":"9","key":"7628_CR10","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1128\/aac.39.9.2167","volume":"39","author":"PA Buffet","year":"1995","unstructured":"Buffet PA, Sulahian A, Garin YJ, Nassar N, Derouin F (1995) Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 39(9):2167\u20132168. https:\/\/doi.org\/10.1128\/aac.39.9.2167","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"7628_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.4269\/ajtmh.18-0949","volume":"101","author":"JBT Carnielli","year":"2019","unstructured":"Carnielli JBT, Monti-Rocha R, Costa DL, Molina Sesana A, Pansini LNN, Segatto M, Mottram JC, Costa CHN, Carvalho SFG, Dietze R (2019) Natural resistance of Leishmania infantum to miltefosine contributes to the low efficacy in the treatment of visceral leishmaniasis in Brazil. Am J Trop Med Hyg 101(4):789\u2013794. https:\/\/doi.org\/10.4269\/ajtmh.18-0949","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"7628_CR12","doi-asserted-by":"publisher","first-page":"12062","DOI":"10.4238\/2015.October.5.19","volume":"14","author":"FS Carvalho","year":"2015","unstructured":"Carvalho FS, Wenceslau AA, Albuquerque GR, Munhoz AD, Gross E, Carneiro PL, Oliveira HC, Rocha JM, Santos IA, Rezende RP (2015) Leishmania (Viannia) braziliensis in dogs in Brazil: epidemiology, co-infection, and clinical aspects. Genet Mol Res 14(4):12062\u201312073. https:\/\/doi.org\/10.4238\/2015.October.5.19","journal-title":"Genet Mol Res"},{"issue":"6","key":"7628_CR13","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1128\/IAI.73.6.3787-3789.2005","volume":"73","author":"PH Da Costa Pinheiro","year":"2005","unstructured":"Da Costa Pinheiro PH, de Souza Dias S, Eul\u00e1lio KD, Mendon\u00e7a IL, Katz S, Barbi\u00e9ri CL (2005) Recombinant cysteine proteinase from Leishmania (Leishmania) chagasi implicated in human and dog T-cell responses. Infect Immun 73(6):3787\u20133789. https:\/\/doi.org\/10.1128\/IAI.73.6.3787-3789.2005","journal-title":"Infect Immun"},{"key":"7628_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fimmu.2020.00345","volume":"11","author":"DAM Da Silva","year":"2020","unstructured":"Da Silva DAM, Santana FR, Katz S, Garcia DM, Teixeira D, Longo-Maug\u00e9ri IM, Barbi\u00e9ri CL (2020a) Protective cellular immune response induction for cutaneous leishmaniasis by a new immunochemotherapy schedule. Front Immunol 11:345. https:\/\/doi.org\/10.3389\/fimmu.2020.00345","journal-title":"Front Immunol"},{"key":"7628_CR15","doi-asserted-by":"publisher","first-page":"105539","DOI":"10.1016\/j.actatropica.2020.105539","volume":"209","author":"JC Da Silva","year":"2020","unstructured":"Da Silva JC, Nunes JB, Gontijo VS, Malaquias LCC, de Freitas RP, Alves RB, Colombo FA, Laurenti MD, Marques MJ (2020b) Leishmanicidal activity in vivo of a miltefosine derivative in Mesocricetus auratus. Acta Trop 209:105539. https:\/\/doi.org\/10.1016\/j.actatropica.2020.105539","journal-title":"Acta Trop"},{"key":"7628_CR16","doi-asserted-by":"publisher","unstructured":"De Carvalho CA, Ferr\u00e3o TF, de Freitas FRN, de Andrade HF J\u00fanior (2019) High levels of serum glycans monovalent IgG immune complexes detected by dissociative ELISA in experimental visceral leishmaniasis. Immunology 158(4):314\u2013321. https:\/\/doi.org\/10.1111\/imm.13118","DOI":"10.1111\/imm.13118"},{"issue":"2","key":"7628_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4269\/ajtmh.2005.72.126","volume":"72","author":"S De Souza Dias","year":"2005","unstructured":"De Souza Dias S, da Costa Pinheiro PH, Katz S, dos Santos MR, Barbi\u00e9ri CL (2005) A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi suitable for serodiagnosis of American visceral leishmaniasis. Am J Trop Med Hyg 72(2):126\u2013132","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"7628_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-3024.1995.tb00914.x","volume":"17","author":"P Deplazes","year":"1995","unstructured":"Deplazes P, Smith NC, Arnold P, Lutz H, Eckert J (1995) Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites. Parasite Immunol 17(9):451\u2013458. https:\/\/doi.org\/10.1111\/j.1365-3024.1995.tb00914.x","journal-title":"Parasite Immunol"},{"key":"7628_CR19","doi-asserted-by":"publisher","first-page":"107947","DOI":"10.1016\/j.exppara.2020.107947","volume":"217","author":"\u00c1FLR Dias","year":"2020","unstructured":"Dias \u00c1FLR, Ayres EDCBS, de Oliveira Martins DT, Maruyama FH, de Oliveira RG, de Carvalho MR, Almeida ADBPF, Teixeira ALS, Mendon\u00e7a AJ, Sousa VRF (2020) Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis. Exp Parasitol 217:107947. https:\/\/doi.org\/10.1016\/j.exppara.2020.107947","journal-title":"Exp Parasitol"},{"issue":"1","key":"7628_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13071-019-3323-0","volume":"12","author":"FN Dos Santos","year":"2019","unstructured":"Dos Santos FN, Avino VC, Galvis-Ovallos F, Pereira-Chioccola VL, Moreira MAB, Romariz APPL, Molla LM, Menz I (2019) Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil. Parasit Vectors 12(1):79. https:\/\/doi.org\/10.1186\/s13071-019-3323-0","journal-title":"Parasit Vectors"},{"issue":"2","key":"7628_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2307\/3283018","volume":"76","author":"TG Evans","year":"1990","unstructured":"Evans TG, Smith D, Pearson RD (1990) Humoral factors and nonspecific immune suppression in Syrian hamsters infected with Leishmania donovani. J Parasitol 76(2):212\u2013217","journal-title":"J Parasitol"},{"issue":"5","key":"7628_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.vaccine.2007.11.044","volume":"26","author":"JH Ferreira","year":"2008","unstructured":"Ferreira JH, Gentil LG, Dias SS, Fedeli CE, Katz S, Barbi\u00e9ri CL (2008) Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis. Vaccine 26(5):677\u2013685. https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.044","journal-title":"Vaccine"},{"issue":"3","key":"7628_CR23","doi-asserted-by":"publisher","first-page":"e2729","DOI":"10.1371\/journal.pntd.0002729","volume":"8","author":"JHL Ferreira","year":"2014","unstructured":"Ferreira JHL, dos Santos SL, Longo-Maug\u00e9ri IM, Katz S, Barbi\u00e9ri CL (2014) Use of a recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi for the immunotherapy of canine visceral leishmaniasis. PLoS Negl Trop Dis 8(3):e2729. https:\/\/doi.org\/10.1371\/journal.pntd.0002729","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"7628_CR24","doi-asserted-by":"publisher","first-page":"e01844","DOI":"10.1128\/mBio.01844-14","volume":"5","author":"LG Gardinassi","year":"2014","unstructured":"Gardinassi LG, Dotz V, HipgraveEderveen A, de Almeida RP, Nery Costa CH, Costa DL, de Jesus AR, Mayboroda OA, Garcia GR, Wuhrer M, de Miranda Santos IK (2014) Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation. mBio 5(6):e01844. https:\/\/doi.org\/10.1128\/mBio.01844-14","journal-title":"mBio"},{"issue":"6","key":"7628_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1748-5827.1998.tb03649.x","volume":"39","author":"PJ Ginel","year":"1998","unstructured":"Ginel PJ, Lucena R, L\u00f3pez R, Molleda JM (1998) Use of allopurinol for maintenance of remission in dogs with leishmaniasis. J Small Anim Pract 39(6):271\u2013274. https:\/\/doi.org\/10.1111\/j.1748-5827.1998.tb03649.x","journal-title":"J Small Anim Pract"},{"issue":"22","key":"7628_CR26","doi-asserted-by":"publisher","first-page":"7845","DOI":"10.1073\/pnas.0712153105","volume":"105","author":"R Gomes","year":"2008","unstructured":"Gomes R, Teixeira C, Teixeira MJ, Oliveira F, Menezes MJ, Silva C, de Oliveira CI, Miranda JC, Elnaiem DE, Kamhawi S, Valenzuela JG, Brodskyn CI (2008) Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Proc Natl Acad Sci U S A 105(22):7845\u20137850. https:\/\/doi.org\/10.1073\/pnas.0712153105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7628_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fcimb.2019.00427","volume":"9","author":"AAM Gon\u00e7alves","year":"2019","unstructured":"Gon\u00e7alves AAM, Leite JC, Resende LA, Mariano RMDS, Silveira P, Melo-J\u00fanior OAO, Ribeiro HS, de Oliveira DS, Soares DF, Santos TAP, Marques AF, Galdino AS, Martins-Filho OA, Dutra WO, da Silveira-Lemos D, Giunchetti RC (2019) An overview of immunotherapeutic approaches against canine visceral leishmaniasis: what has been tested on dogs and a new perspective on improving treatment efficacy. Front Cell Infect Microbiol 9:427. https:\/\/doi.org\/10.3389\/fcimb.2019.00427","journal-title":"Front Cell Infect Microbiol"},{"key":"7628_CR28","doi-asserted-by":"publisher","unstructured":"Guarga JL, Moreno J, Lucientes J, Gracia MJ, Perib\u00e1\u00f1ez MA, Castillo JA (2002) Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis. Vet Immunol Immunopathol 88(1\u20132):13\u201320. https:\/\/doi.org\/10.1016\/s0165-2427(02)00128-9","DOI":"10.1016\/s0165-2427(02)00128-9"},{"issue":"2","key":"7628_CR29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/jac\/dkr485","volume":"67","author":"R Gupta","year":"2012","unstructured":"Gupta R, Kushawaha PK, Samant M, Jaiswal AK, Baharia RK, Dube A (2012) Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses. J Antimicrob Chemother 67(2):440\u2013443. https:\/\/doi.org\/10.1093\/jac\/dkr485","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"7628_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.pt.2011.04.001","volume":"27","author":"MO Harhay","year":"2011","unstructured":"Harhay MO, Olliaro PL, Costa DL, Costa CH (2011) Urban parasitology: visceral leishmaniasis in Brazil. Trends Parasitol 27(9):403\u2013409. https:\/\/doi.org\/10.1016\/j.pt.2011.04.001","journal-title":"Trends Parasitol"},{"issue":"4","key":"7628_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1017\/S0031182016002031","volume":"145","author":"S Hendrickx","year":"2018","unstructured":"Hendrickx S, Guerin PJ, Caljon G, Croft SL, Maes L (2018) Evaluating drug resistance in visceral leishmaniasis: the challenges. Parasitology 145(4):453\u2013463. https:\/\/doi.org\/10.1017\/S0031182016002031","journal-title":"Parasitology"},{"issue":"3","key":"7628_CR32","first-page":"26","volume":"6","author":"Sh Jamshidi","year":"2011","unstructured":"Jamshidi Sh, Avizeh R, Mohebali M, Bokaie S (2011) Immunotherapy using autoclaved L. major antigens and M. vaccae with meglumine antimoniate, for the treatment of experimental canine visceral leishmaniasis. Iran J Parasitol 6(3):26\u201334","journal-title":"Iran J Parasitol"},{"key":"7628_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ejps.2018.06.002","volume":"121","author":"MD Jim\u00e9nez-Ant\u00f3n","year":"2018","unstructured":"Jim\u00e9nez-Ant\u00f3n MD, Garc\u00eda-Calvo E, Guti\u00e9rrez C, Escribano MD, Kayali N, Luque-Garc\u00eda JL, Ol\u00edas-Molero AI, Corral MJ, Costi MP, Torrado JJ, Alunda JM (2018) Pharmacokinetics and disposition of miltefosine in healthy mice and hamsters experimentally infected with Leishmania infantum. Eur J Pharm Sci 121:281\u2013286. https:\/\/doi.org\/10.1016\/j.ejps.2018.06.002","journal-title":"Eur J Pharm Sci"},{"key":"7628_CR34","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez-Ant\u00f3n\u00a0MD, Grau M, Ol\u00edas-Molero AI, Alunda JM (2019) Syrian hamster as an advanced experimental model for visceral leishmaniasis. Methods Mol Biol 1971:303\u2013314. https:\/\/doi.org\/10.1007\/978-1-4939-9210-2_17","DOI":"10.1007\/978-1-4939-9210-2_17"},{"issue":"17","key":"7628_CR35","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.vaccine.2018.03.027","volume":"36","author":"YNK Keerti","year":"2018","unstructured":"Keerti YNK, Joshi S, Ratnapriya S, Sahasrabuddhe AA, Dube A (2018) Immunotherapeutic potential of Leishmania (Leishmania) donovani Th1 stimulatory proteins against experimental visceral leishmaniasis. Vaccine 36(17):2293\u20132299. https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.027","journal-title":"Vaccine"},{"key":"7628_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.actatropica.2015.04.002","volume":"148","author":"FO Lara-Silva","year":"2015","unstructured":"Lara-Silva FO, Michalsky \u00c9M, Fortes-Dias CL (2015) Epidemiological aspects of vector, parasite, and domestic reservoir in areas of recent transmission and no reported human cases of visceral leishmaniasis in Brazil. Acta Trop 148:128\u2013136. https:\/\/doi.org\/10.1016\/j.actatropica.2015.04.002","journal-title":"Acta Trop"},{"key":"7628_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"4","key":"7628_CR38","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1128\/AAC.01415-06","volume":"51","author":"JR Luque-Ortega","year":"2007","unstructured":"Luque-Ortega JR, Rivas L (2007) Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes. Antimicrob Agents Chemother 51(4):1327\u20131332. https:\/\/doi.org\/10.1128\/AAC.01415-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"7628_CR39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.tvjl.2008.08.009","volume":"182","author":"L Manna","year":"2009","unstructured":"Manna L, Vitale F, Reale S, Picillo E, Neglia G, Vescio F, Gravino AE (2009) Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis. Vet J 182(3):441\u2013445. https:\/\/doi.org\/10.1016\/j.tvjl.2008.08.009","journal-title":"Vet J"},{"key":"7628_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13071-015-0896-0","volume":"8","author":"L Manna","year":"2015","unstructured":"Manna L, Corso R, Galiero G, Cerrone A, Muzi P, Gravino AE (2015) Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniante plus allopurinol versus miltefosine plus allopurinol. Parasit Vectors 8:289. https:\/\/doi.org\/10.1186\/s13071-015-0896-0","journal-title":"Parasit Vectors"},{"key":"7628_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.rvsc.2019.01.022","volume":"123","author":"M Marcondes","year":"2019","unstructured":"Marcondes M, Day MJ (2019) Current status and management of canine leishmaniasis in Latin America. Res Vet Sci 123:261\u2013272. https:\/\/doi.org\/10.1016\/j.rvsc.2019.01.022","journal-title":"Res Vet Sci"},{"issue":"4","key":"7628_CR42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1590\/s0100-879x2001000400015","volume":"34","author":"R Mathias","year":"2001","unstructured":"Mathias R, Costa FA, Goto H (2001) Detection of immunoglobulin G in the lung and liver of hamsters with visceral leishmaniasis. Braz J Med Biol Res 34(4):539\u2013543. https:\/\/doi.org\/10.1590\/s0100-879x2001000400015","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"7628_CR43","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1128\/IAI.66.5.2135-2142.1998","volume":"66","author":"PC Melby","year":"1998","unstructured":"Melby PC, Tryon VV, Chandrasekar B, Freeman GL (1998) Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis. Infect Immun 66(5):2135\u20132142. https:\/\/doi.org\/10.1128\/IAI.66.5.2135-2142.1998","journal-title":"Infect Immun"},{"issue":"3","key":"7628_CR44","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","volume":"166","author":"PC Melby","year":"2001","unstructured":"Melby PC, Chandrasekar B, Zhao W, Coe JE (2001) The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J Immunol 166(3):1912\u20131920. https:\/\/doi.org\/10.4049\/jimmunol.166.3.1912","journal-title":"J Immunol"},{"issue":"5\u20136","key":"7628_CR45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-3164.2009.00824.x","volume":"20","author":"G Mir\u00f3","year":"2009","unstructured":"Mir\u00f3 G, Oliva G, Cruz I, Ca\u00f1avate C, Mortarino M, Vischer C, Bianciardi P (2009) Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. Vet Dermatol 20(5\u20136):397\u2013404. https:\/\/doi.org\/10.1111\/j.1365-3164.2009.00824.x","journal-title":"Vet Dermatol"},{"issue":"4","key":"7628_CR46","doi-asserted-by":"publisher","first-page":"e0154101","DOI":"10.1371\/journal.pone.0154101","volume":"11","author":"A Mondelaers","year":"2016","unstructured":"Mondelaers A, Sanchez-Ca\u00f1ete MP, Hendrickx S, Eberhardt E, Garcia-Hernandez R, Lachaud L, Cotton J, Sanders M, Cuypers B, Imamura H, Dujardin JC, Delputte P, Cos P, Caljon G, Gamarro F, Castanys S, Maes L (2016) Genomic and molecular characterization of miltefosine resistance in Leishmania infantum strains with either natural or acquired resistance through experimental selection of intracellular amastigotes. PLoS ONE 11(4):e0154101. https:\/\/doi.org\/10.1371\/journal.pone.0154101","journal-title":"PLoS ONE"},{"key":"7628_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13071-016-1464-y","volume":"9","author":"ND Moreira","year":"2016","unstructured":"Moreira ND, Vitoriano-Souza J, Roatt BM, Vieira PM, Coura-Vital W, Cardoso JM, Rezende MT, Ker HG, Giunchetti RC, Carneiro CM, Reis AB (2016) Clinical, hematological and biochemical alterations in hamster (Mesocricetus auratus) experimentally infected with Leishmania infantum through different routes of inoculation. Parasit Vectors 9:181. https:\/\/doi.org\/10.1186\/s13071-016-1464-y","journal-title":"Parasit Vectors"},{"issue":"9496","key":"7628_CR48","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","volume":"366","author":"HW Murray","year":"2009","unstructured":"Murray HW, Berman JD, Davies CR, Saravia NG (2009) Advances in leishmaniasis. Lancet 366(9496):1561\u20131577. https:\/\/doi.org\/10.1016\/S0140-6736(05)67629-5","journal-title":"Lancet"},{"issue":"1","key":"7628_CR49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/0035-9203(85)90255-x","volume":"79","author":"RA Neal","year":"1985","unstructured":"Neal RA, Croft SL, Nelson DJ (1985) Anti-leishmanial effect of allopurinol ribonucleoside and the related compounds, allopurinol, thiopurinol, thiopurinol ribonucleoside, and of formycin B, sinefungin and the lepidine WR6026. Trans R Soc Trop Med Hyg 79(1):122\u2013128. https:\/\/doi.org\/10.1016\/0035-9203(85)90255-x","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"7628_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0304-4017(94)90003-5","volume":"54","author":"AB Neogy","year":"1994","unstructured":"Neogy AB, Vouldoukis I, da Costa JM, Monjour L (1994) Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Group of Lupino. Vet Parasitol 54(4):367\u2013373. https:\/\/doi.org\/10.1016\/0304-4017(94)90003-5","journal-title":"Vet Parasitol"},{"issue":"2","key":"7628_CR51","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0165-2427(98)00213-x","volume":"67","author":"CG Nieto","year":"1999","unstructured":"Nieto CG, Garc\u00eda-Alonso M, Requena JM, Mir\u00f3n C, Soto M, Alonso C, Navarrete I (1999) Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis. Vet Immunol Immunopathol 67(2):117\u2013130. https:\/\/doi.org\/10.1016\/s0165-2427(98)00213-x","journal-title":"Vet Immunol Immunopathol"},{"key":"7628_CR52","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.tvjl.2014.09.002","volume":"202","author":"C Noli","year":"2014","unstructured":"Noli C, Saridomichelakis MN (2014) An update on the diagnosis and treatment of canine leishmaniosis caused by Leishmania infantum (syn. L. chagasi). Vet J 202:425\u2013435. https:\/\/doi.org\/10.1016\/j.tvjl.2014.09.002","journal-title":"Vet J"},{"key":"7628_CR53","doi-asserted-by":"publisher","first-page":"108921","DOI":"10.1016\/j.vetpar.2019.108921","volume":"274","author":"N Parody","year":"2019","unstructured":"Parody N, Cacheiro-Llaguno C, Osunaa C, Renshaw-Calder\u00f3n A, Alonso C, Carn\u00e9s J (2019) Circulating immune complexes levels correlate with the progression of canine leishmaniosis in naturally infected dogs. Vet Parasitol 274:108921. https:\/\/doi.org\/10.1016\/j.vetpar.2019.108921","journal-title":"Vet Parasitol"},{"issue":"1 Pt 2","key":"7628_CR54","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4269\/ajtmh.1992.47.8","volume":"47","author":"RD Pearson","year":"1992","unstructured":"Pearson RD, Cox G, Jeronimo SM, Castracane J, Drew JS, Evans T, de Alencar JE (1992) Visceral leishmaniasis: a model for infection-induced cachexia. Am J Trop Med Hyg 47(1 Pt 2):8\u201315. https:\/\/doi.org\/10.4269\/ajtmh.1992.47.8","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"7628_CR55","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1128\/AAC.5.5.469","volume":"5","author":"MA Pfaller","year":"1974","unstructured":"Pfaller MA, Marr JJ (1974) Antileishmanial effect of allopurinol. Antimicrob Agents Chemother 5(5):469\u2013472. https:\/\/doi.org\/10.1128\/AAC.5.5.469","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"7628_CR56","doi-asserted-by":"publisher","first-page":"e01614","DOI":"10.1128\/AAC.01614-17","volume":"62","author":"AK Pinto-Martinez","year":"2017","unstructured":"Pinto-Martinez AK, Rodriguez-Dur\u00e1n J, Serrano-Martin X, Hernandez-Rodriguez V, Benaim G (2017) Mechanism of action of miltefosine on Leishmania donovani involves the impairment of acidocalcisome function and the activation of the sphingosine-dependent plasma membrane Ca2+ channel. Antimicrob Agents Chemother 62(1):e01614-e1617. https:\/\/doi.org\/10.1128\/AAC.01614-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"7628_CR57","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1939-1676.2006.tb02850.x","volume":"20","author":"K Plevraki","year":"2006","unstructured":"Plevraki K, Koutinas AF, Kaldrymidou H, Roumpies N, Papazoglou LG, Saridomichelakis MN, Savvas I, Leondides L (2006) Effects of allopurinol treatment on the progression of chronic nephritis in canine leishmaniosis (Leishmania infantum). J Vet Intern Med 20(2):228\u2013233. https:\/\/doi.org\/10.1111\/j.1939-1676.2006.tb02850.x","journal-title":"J Vet Intern Med"},{"issue":"2","key":"7628_CR58","doi-asserted-by":"publisher","first-page":"e0003556","DOI":"10.1371\/journal.pntd.0003556","volume":"9","author":"JQ Reim\u00e3o","year":"2015","unstructured":"Reim\u00e3o JQ, Oliveira JC, Trinconi CT, Cotrim PC, Coelho AC, Uliana SR (2015) Generation of luciferase expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging. PLoS Negl Trop Dis 9(2):e0003556. https:\/\/doi.org\/10.1371\/journal.pntd.0003556","journal-title":"PLoS Negl Trop Dis"},{"key":"7628_CR59","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s0165-2427(00)00221-x","volume":"76","author":"JM Requena","year":"2000","unstructured":"Requena JM, Soto M, Doria MD, Alonso C (2000) Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model. Vet Immunol Immunopathol 76:269\u2013281. https:\/\/doi.org\/10.1016\/s0165-2427(00)00221-x","journal-title":"Vet Immunol Immunopathol"},{"key":"7628_CR60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fimmu.2017.00217","volume":"8","author":"BM Roatt","year":"2017","unstructured":"Roatt BM, Aguiar-Soares RD, Reis LE, Cardoso JM, Mathias FA, de Brito RC, da Silva SM, Gontijo NF, Ferreira SA, Valenzuela JG, Corr\u00eaa-Oliveira R, Giunchetti RC, Reis AB (2017) A vaccine therapy for canine visceral leishmaniasis promoted significant improvement of clinical and immune status with reduction in parasite burden. Front Immunol 8:217. https:\/\/doi.org\/10.3389\/fimmu.2017.00217","journal-title":"Front Immunol"},{"issue":"33","key":"7628_CR61","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1016\/j.vaccine.2007.06.005","volume":"25","author":"FN Santos","year":"2007","unstructured":"Santos FN, Borja-Cabrera GP, Miyashiro LM, Grechi J, Reis AB, Moreira MA, Martins Filho OA, Luvizotto MC, Menz I, Pess\u00f4a LM, Gon\u00e7alves PR, Palatnik M, Palatnik-de-Sousa CB (2007) Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccine. Vaccine 25(33):6176\u20136190. https:\/\/doi.org\/10.1016\/j.vaccine.2007.06.005","journal-title":"Vaccine"},{"issue":"13","key":"7628_CR62","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.vaccine.2005.11.061","volume":"24","author":"EM Saraiva","year":"2006","unstructured":"Saraiva EM, de Figueiredo BA, Santos FN, Borja-Cabrera GP, Nico D, Souza LO, de Oliveira M-A, de Souza EP, Fampa P, Parra LE, Menz I, Dias JG Jr, de Oliveira SM, Palatnik-de-Sousa CB (2006) The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine. Vaccine 24(13):2423\u20132431. https:\/\/doi.org\/10.1016\/j.vaccine.2005.11.061","journal-title":"Vaccine"},{"issue":"9","key":"7628_CR63","doi-asserted-by":"publisher","first-page":"e0162854","DOI":"10.1371\/journal.pone.0160058","volume":"11","author":"AP Sev\u00e1","year":"2016","unstructured":"Sev\u00e1 AP, Ovallos FG, Amaku M, Carrillo E, Moreno J, Galati EA, Lopes EG, Soares RM, Ferreira F (2016) Canine-based strategies for prevention and control of visceral leishmaniasis in Brazil. PLoS One 11(9):e0162854. https:\/\/doi.org\/10.1371\/journal.pone.0160058","journal-title":"PLoS One"},{"key":"7628_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/prep.1998.1003","volume":"15","author":"P Sheffield","year":"1999","unstructured":"Sheffield P, Garrard S, Derewenda Z (1999) Overcoming expression and purification problems of RhoGDI using a family of \u201cparallel\u201d expression vectors. Prot Expres Purif 15:34\u201339. https:\/\/doi.org\/10.1006\/prep.1998.1003","journal-title":"Prot Expres Purif"},{"issue":"4","key":"7628_CR65","doi-asserted-by":"publisher","first-page":"e94596","DOI":"10.1371\/journal.pone.0094596","volume":"9","author":"R Shivahare","year":"2014","unstructured":"Shivahare R, Vishwakarma P, Parmar N, Yadav PK, Haq W, Srivastava M, Gupta S, Kar S (2014) Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis. PLoS ONE 9(4):e94596. https:\/\/doi.org\/10.1371\/journal.pone.0094596","journal-title":"PLoS ONE"},{"issue":"5","key":"7628_CR66","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1590\/S0036-46652015000500012","volume":"57","author":"DA Silva","year":"2015","unstructured":"Silva DA, Madeira Mde F, Figueiredo FB (2015) Geographical expansion of canine visceral leishmaniasis in Rio de Janeiro State, Brazil. Rev Inst Med Trop S\u00e3o Paulo 57(5):435\u2013438. https:\/\/doi.org\/10.1590\/S0036-46652015000500012","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"issue":"31\u201332","key":"7628_CR67","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1016\/s0264-410x(02)00302-x","volume":"20","author":"YA Skeiky","year":"2002","unstructured":"Skeiky YA, Coler RN, Brannon M, Stromberg E, Greeson K, Crane RT, Webb JR, Campos-Neto A, Reed SG (2002) Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant. Vaccine 20(31\u201332):3292\u20133303. https:\/\/doi.org\/10.1016\/s0264-410x(02)00302-x","journal-title":"Vaccine"},{"issue":"3","key":"7628_CR68","doi-asserted-by":"publisher","first-page":"e01169","DOI":"10.1128\/AAC.01169-16","volume":"61","author":"B Tiwari","year":"2017","unstructured":"Tiwari B, Pahuja R, Kumar P, Rath SK, Gupta KC, Goyal N (2017) Nanotized curcumin and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis. Antimicrob Agents Chemother 61(3):e01169-e1216. https:\/\/doi.org\/10.1128\/AAC.01169-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"43","key":"7628_CR69","doi-asserted-by":"publisher","first-page":"6433","DOI":"10.1016\/j.vaccine.2018.08.087","volume":"36","author":"A Toepp","year":"2018","unstructured":"Toepp A, Larson M, Wilson G, Grinnage-Pulley T, Bennett C, Leal-Lima A, Anderson B, Parrish M, Anderson M, Fowler H, Hinman J, Kontowicz E, Jefferies J, Beeman M, Buch J, Saucier J, Tyrrell P, Gharpure R, Cotter C, Petersen C (2018) Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosis. Vaccine 36(43):6433\u20136441. https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.087","journal-title":"Vaccine"},{"issue":"19","key":"7628_CR70","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/j.vaccine.2010.02.089","volume":"28","author":"J Trigo","year":"2010","unstructured":"Trigo J, Abbehusen M, Netto EM, Nakatani M, Pedral-Sampaio G, de Jesus RS, Goto Y, Guderian J, Howard RF, Reed SG (2010) Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE. Vaccine 28(19):3333\u20133340. https:\/\/doi.org\/10.1016\/j.vaccine.2010.02.089","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"7628_CR71","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.trstmh.2006.03.010","volume":"100","author":"JA Urbina","year":"2006","unstructured":"Urbina JA (2006) Mechanisms of action of lysophospholipid analogues against trypanosomatid parasites. Trans R Soc Trop Med Hyg 100(Suppl 1):S9\u2013S16. https:\/\/doi.org\/10.1016\/j.trstmh.2006.03.010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"7628_CR72","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.vetpar.2018.03.010","volume":"254","author":"KF Viana","year":"2018","unstructured":"Viana KF, Lacerda G, Teixeira NS, Rodrigues Cangussu AS, Sousa Aguiar RW, Giunchetti R (2018) Therapeutic vaccine of killed Leishmania amazonensis plus saponin reduced parasite burden in dogs naturally infected with Leishmania infantum. Vet Parasitol 254:98\u2013104. https:\/\/doi.org\/10.1016\/j.vetpar.2018.03.010","journal-title":"Vet Parasitol"},{"key":"7628_CR73","unstructured":"World Health Organization (WHO) (2020) Leishmaniasis. https:\/\/www.who.int\/mediacentre\/factsheets\/fs375\/en\/. Accessed 01 Oct 2020"},{"key":"7628_CR74","doi-asserted-by":"publisher","first-page":"e0004341","DOI":"10.1371\/journal.pntd.0004341","volume":"10","author":"D Yasur-Landau","year":"2016","unstructured":"Yasur-Landau D, Jaffe CL, David L, Baneth G (2016) Allopurinol resistance in Leishmania infantum from dogs with disease relapse. PLoS Negl Trop Dis 10:e0004341. https:\/\/doi.org\/10.1371\/journal.pntd.0004341","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-022-07628-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-022-07628-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-022-07628-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T08:49:58Z","timestamp":1727858998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-022-07628-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":74,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["7628"],"URL":"https:\/\/doi.org\/10.1007\/s00436-022-07628-y","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"24 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}